Sepsis biomarkers in polytrauma patients

Area of Science:

• Trauma and Injury Research
• Immunology
• Biomarker Discovery

Background:

• Traumatic injury is a leading cause of death in Americans, often following a tri-modal mortality pattern.
• The late phase of this pattern is characterized by immune dysfunction, increasing susceptibility to septic complications.
• Current medical care and injury prevention have not eliminated sepsis as a major cause of death in trauma patients.

Purpose of the Study:

• To highlight the critical need for specific biomarkers to detect post-traumatic infection and sepsis.
• To review existing and emerging biomarkers for infection and sepsis following trauma.
• To discuss the role of immune dysfunction in trauma-related mortality.

Main Methods:

• Literature review of biomarkers for infection and sepsis in trauma patients.
• Discussion of various biomarker categories including inflammatory cytokines, intracellular proteins, and cellular biomarkers.
• Analysis of the temporal pattern of mortality following traumatic injury.

Main Results:

• Trauma-induced immune dysfunction in the late phase significantly contributes to septic complications and mortality.
• Several classes of biomarkers, including cytokines and cellular markers, show potential for early infection detection.
• Emerging biomarkers offer new avenues for diagnosing sepsis in critically ill trauma patients.

Conclusions:

• Effective biomarkers for post-traumatic infection are urgently needed to guide clinical management.
• Monitoring immune status and specific molecular markers can help predict and manage sepsis in trauma survivors.
• Further research into novel biomarkers is essential to reduce septic complications and improve survival rates in trauma patients.